Chemoradiation after Surgery for High-Risk Head and Neck Cancer Patients: How Strong Is the Evidence?

Chemoradiation after Surgery for High-Risk Head and Neck Cancer Patients: How Strong Is the Evidence? Jacques Bernier, Jay S. Cooper Oncologist 2005; 10: 215-224 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in head and neck cancers and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: List the clinical and histopathologic risk factors that motivate a more aggressive adjuvant treatment in patients with locally advanced head and neck cancer. Evaluate the impact of postoperative radiotherapy and chemoradiation on treatment outcome for a variety of efficacy and toxicity end points. Identify the most efficient chemotherapy agents in chemoradiation protocols for head and neck cancer patients. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Mar. 25, 2005 Most Recent Review: Mar. 25, 2005* Most Recent Update: Mar. 25, 2005 Date Credit Expires: Apr. 12, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.